US Stock MarketDetailed Quotes

KA Kineta

Watchlist

0.590
+0.013+2.16%

Close Aug 8 16:00 ET

7.23MMarket Cap-359P/E (TTM)

Kineta Stock Forum

Mcsnacks H Tupack

Jul 11 02:33

Making big moves

$Kineta (KA.US)$ broke resistance. Uptrending to 2.20. Borrow rate doubled and no shares available.

Stock Region

Jul 8 13:49

Biotechnology Company Announces Major Agreement For Worldwide Exclusive Rights

Kineta Announces Exclusivity and Right of First Offer Agreement for VISTA Blocking Antibody with TuHURA Biosciences.
Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company dedicated to the development of novel immunotherapies aimed at overcoming cancer immune resistance, has recently announced a massive milestone. The company has entered into an exclusivity and right of first offer agreement (the "Agreement"...

Stock_Drift

Jul 8 07:57

7/8/24 watchlist 🚨🚨🚨🚨
$Inspire Veterinary Partners (IVP.US)$ $Zapp Electric Vehicles (ZAPP.US)$ $CERo Therapeutics (CERO.US)$ $Maxeon Solar Technologies (MAXN.US)$ $Kineta (KA.US)$
📊⚡️📊

Jaguar8

Jul 8 05:30

NEWS

$Kineta (KA.US)$
Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences
Kineta has entered an exclusivity and right of first offer agreement with TuHURA Biosciences for its KVA12123 immuno-oncology drug program. Under the agreement, TuHURA has the exclusive right to negotiate the acquisition of Kineta's assets, patents, and development program related to KVA12123. This right is valid until October 1, 2024, with possible extensio...